Intellipharmaceutics International Inc (IPCIF) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2023 and for the year 2023, average high and low, overall ranking from Nov 30 2022 to May 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intellipharmaceutics International Inc   (IPCIF)


Intellipharmaceutics International Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Intellipharmaceutics International Inc's ROI in the fourth quarter of 2023?
Intellipharmaceutics International Inc recorded a cumulative net loss of $-6 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -526.94%.

Within the Healthcare sector 1070 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 0 to 5522.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Nov 30 2022)
IV. Quarter		 0
III. Quarter		 (Aug 31 2023)
III. Quarter		 0
II. Quarter		 (May 31 2023)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 4 -7 3 -11
Return On Investment (TTM) -526.94 % 114.2 % - 60.45 % -
IPCIF's Overall Ranking # 5522 # 0 # 0 # 0 #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -6 -3 -4 -2 -1

IPCIF Company Profile >> Back to IPCIF Roi Comparisons >> See Annual IPCIF Return On Investment



Return On Investment IPCIF's Ranking
Within: No.
Industry # 519
Sector # 1071
Overall # 5522

Return On Investment Statistics
High Average Low
-201.98 %
-462.83 %
-723.68 %
(Nov 30 2022)   (Nov 30 2013)







Financial Statements
Intellipharmaceutics International Inc's IV. Quarter Investments $ 5 Millions IPCIF's Balance sheet
Intellipharmaceutics International Inc's IV. Quarter Income $ -3 Millions Quarterly IPCIF's Income Statement
IPCIF's Income by Division See IPCIF's Income by Division


IPCIF Annual Return On Investment (Nov 30 2022)
2023		 (Nov 30 2020)
2021		 (Nov 30 2020)
2020		 (Nov 30 2019)
2019		 (Nov 30 2018)
2018
Total Investments in Millions 1 -6 -4 -2 8
Y / Y Investment Growth - - - - 97.33 %
Net Income in Millions -3 5 3 -8 0
Y / Y Net Income Growth - 51.73 % - - -
Annual Return On Investment -201.98 % - - - 0 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IPCIF's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IPCIF's Competitors
Subscribers only: Roi for Intellipharmaceutics International Inc's Suppliers
Subscribers only: Return On Investment for IPCIF's Customers

Other Ratios
IPCIF's Roa IPCIF's Inventory Turnover Ratio IPCIF's Growth Rates IPCIF's Dividend Statistics
IPCIF's Profitability Ratios IPCIF's Asset Turnover Ratio IPCIF's Dividend Growth
IPCIF's Roe IPCIF's Valuation Ratios IPCIF's Financial Strength Ratios IPCIF's Dividend Payout Ratio



Companies with similar Return On Investment at Nov 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-12T06:20:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.